Catalent (CTLT) to Report Q2 Earnings: What’s in the Cards? Posted byZacks Equity Research January 25, 2022 Leave a comment on Catalent (CTLT) to Report Q2 Earnings: What’s in the Cards? Catalent’s (CTLT) Biologics segment is likely to have maintained its impressive performance over the past few months, thereby aiding Q2 results.